Center for Disease Analysis Foundation Awards Second Round of Grants for the CDAF-Relink Program
30 Julio 2024 - 11:05AM
Business Wire
As part of the ongoing CDAF-Relink program to reconnect US-based
individuals infected with hepatitis C (HCV) or hepatitis B (HBV) to
care, the Center for Disease Analysis Foundation (CDA Foundation)
is pleased to announce 1.8 million dollars in the second round of
grants. The following 11 organizations are beneficiaries:
Organization
Organization Type
State
Boston Health Care for the Homeless
Program
Healthcare Institution
MA
Central City Concern
Non-Profit
OR
Community HealthNet
Healthcare Institution
IN
Iowa Department of Health and Human
Services
State Health Agency
IA
Montefiore Medical Center
Healthcare Institution
NY
Mount Sinai, Icahn School of Medicine
Healthcare Institution
NY
Prisma Health
Healthcare Institution
SC
Sentara Martha Jefferson Hospital
Healthcare Institution
VA
University of Colorado Anschutz Medical
Campus
Healthcare Institution
CO
University of Miami Miller School of
Medicine
Healthcare Institution
FL
University of Southern California
Healthcare Institution
CA
“This award will allow us to add a Re-Engagement Specialist to
our team,” stated Cody Shafer-Fritz, Lead Prevention Services
Coordinator at Iowa Department of Health and Human Services. “The
person in this role will work to connect individuals to treatment
in a variety of settings throughout Iowa HHS’s existing
partnerships. Treatment is a core strategy of our efforts to end
the HCV epidemic in Iowa. We look forward to increasing our
capacity to support the health and well-being of Iowans impacted by
HCV.”
The CDAF-Relink program is sponsored by an eight-million-dollar
grant from Gilead Sciences (Nasdaq: GILD) as part of Gilead’s
Relink grant program. Around the world, relink programs have shown
success in reconnecting HCV and HBV infected individuals to care.
Challenges remain, nonetheless, the main ones being identifying
infected individuals based on available medical records,
successfully contacting them, and navigating personal and
institutional barriers to care. Building on the successes and
lessons learned from the ongoing efforts of round one grantees,
round two and subsequent rounds will continue to implement
evidence-based approaches, leveraging successful interventions and
data collection models, while emphasizing knowledge and resource
sharing.
“Hepatitis B and C infections are now the leading cause of death
globally among all infectious diseases, and we have all the tools
to eliminate these infections in the United States,” commented
Homie Razavi, the Managing Director of CDA Foundation. “Loss of
diagnosed but untreated patients is a major public health barrier
in the U.S. to achieving the viral hepatitis elimination targets.
Our second round of grantees will work with general and
marginalized populations to link an estimated 5,400 diagnosed but
untreated HCV and HBV infected individuals back into physicians’
care. We are grateful for all 25 applicants who took the time to
submit a grant and will work with the organizations who were not
funded to update their proposals for the next round of
funding.”
The call for round three proposals will open in August 2024 with
proposals from state health agencies given a priority. For more
information, please visit https://cdafound.org/relink or contact
the CDAF-Relink program at relink@cdafound.org.
About Center for Disease Analysis
Foundation
CDA Foundation is a non-profit organization that seeks to help
eliminate HBV and HCV globally by 2030 by providing countries
across the world with verified epidemiological data, disease burden
and economic impact modeling, smart intervention strategies, access
to affordable diagnostics and treatments, innovative financing, and
knowledge-sharing partnerships to eliminate these deadly
infections. It works with more than 110 countries globally and 26
US states on their viral hepatitis elimination programs. CDA
Foundation is headquartered in Lafayette.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240729658449/en/
Homie Razavi hrazavi@cdafound.org